Covered recipient · General Payments record
RACHEL RABER
Allopathic & Osteopathic Physicians Otolaryngology Plastic Surgery within the Head & Neck
General Payments · PY2021–2023
$577.10
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.93 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acclarent, Inc | $204.54 | 5 |
| Regeneron Healthcare Solutions, Inc. | $27.15 | 1 |
| OptiNose US, Inc. | $21.75 | 1 |
| GlaxoSmithKline, LLC. | $20.37 | 1 |
| Acerta Pharma LLC | $17.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acclarent, Inc | $18.85 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990818957 | CMS |
| Acclarent, Inc | $44.76 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990818949 | CMS |
| Acclarent, Inc | $48.43 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990818965 | CMS |
| Acclarent, Inc | $36.90 | 09/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990818973 | CMS |
| Acclarent, Inc | $55.60 | 11/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 990818941 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.12 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051634505 | CMS |
| GlaxoSmithKline, LLC. | $20.37 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003596053 | CMS |
| Optinose US, Inc. | $21.75 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1035143573 | CMS |
| Regeneron Healthcare Solutions, Inc. | $27.15 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999852077 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.